Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03975660 · ClinicalTrials.gov registry record · NA
Evaluation of Objective Pain Measurement Device
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT03975660: Completed NA study, sponsored by Stanford University.
NCT03975660 is a NA study that has completed, run by Stanford University. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03975660, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
This study will attempt to objectively measure pain with an experimental device. The investigators will apply the device to measure patients "pain" due to uterine contractions during routine clinical care to correlate patients verbal pain ratings and analgesia requirements to that measured by the device. A brain oxygenation device, Edwards Foresight, will be used to concurrently to monitor brain oxygenation and hemodynamics, so the relationship between the CereVu ROPA device objective measure of pain and brain oxygenation/hemodynamic changes and patient-reported pain can be determined.
Interventions
- DEVICE Pain Measurement Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2023-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03975660
The ClinicalTrials.gov registry entry for NCT03975660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pain Measurement Device is the first listed.
NCT03975660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03975660 about?
NCT03975660 is a clinical study titled "Evaluation of Objective Pain Measurement Device". This study will attempt to objectively measure pain with an experimental device. The investigators will apply the device to measure patients "pain" due to uterine contractions during routine clinical care to correlate patients verbal pain ratings and analgesia requirements to that measured by the de...
What is the current status of trial NCT03975660?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2019-11-01. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT03975660?
The interventions under investigation include: Pain Measurement Device (DEVICE).
Who is sponsoring clinical trial NCT03975660?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.